BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22054074)

  • 1. TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.
    Zhu C; Di D; Zhang X; Luo G; Wang Z; Wei J; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
    Lipids Health Dis; 2011 Nov; 10():199. PubMed ID: 22054074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
    Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
    Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXR-agonists regulate ApoM expression differentially in liver and intestine.
    Calayir E; Becker TM; Kratzer A; Ebner B; Panzenböck U; Stefujl J; Kostner GM
    Curr Pharm Biotechnol; 2008 Dec; 9(6):516-21. PubMed ID: 19075690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
    Jasmin SB; Pearson V; Lalonde D; Domenger D; Théroux L; Poirier J
    Brain Res; 2014 May; 1562():39-51. PubMed ID: 24661912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor inhibits the synthesis and secretion of apolipoprotein A1 by human liver-derived cells.
    Huuskonen J; Vishnu M; Chau P; Fielding PE; Fielding CJ
    Biochemistry; 2006 Dec; 45(50):15068-74. PubMed ID: 17154544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
    Zhang X; Zhu Z; Luo G; Zheng L; Nilsson-Ehle P; Xu N
    Biochem Biophys Res Commun; 2008 Jun; 371(1):114-7. PubMed ID: 18413148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
    Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
    Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
    Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
    Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
    Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein M regulates the orphan nuclear receptor LRH-1 gene expression through binding to its promoter region in HepG2 cells.
    Pan Y; Zhou HG; Zhou H; Hu M; Tang LJ
    Drug Des Devel Ther; 2015; 9():2375-82. PubMed ID: 25987835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver.
    Luo G; Feng Y; Zhang J; Mu Q; Shi Y; Qin L; Zheng L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
    Int J Med Sci; 2014; 11(10):1015-21. PubMed ID: 25136257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
    Murthy S; Born E; Mathur SN; Field FJ
    J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
    Yang L; Zhao S
    Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
    Trasino SE; Kim YS; Wang TT
    Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.
    Jiang H; Badralmaa Y; Yang J; Lempicki R; Hazen A; Natarajan V
    Lipids Health Dis; 2012 Jul; 11():69. PubMed ID: 22676378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes.
    Tsezou A; Iliopoulos D; Malizos KN; Simopoulou T
    J Orthop Res; 2010 Aug; 28(8):1033-9. PubMed ID: 20108316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.
    Mulya A; Seo J; Brown AL; Gebre AK; Boudyguina E; Shelness GS; Parks JS
    J Lipid Res; 2010 Mar; 51(3):514-24. PubMed ID: 19767535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TO901317, a potent LXR agonist, is an inverse agonist of CAR.
    Kanno Y; Tanuma N; Takahashi A; Inouye Y
    J Toxicol Sci; 2013; 38(3):309-15. PubMed ID: 23665929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.